<DOC>
	<DOCNO>NCT02183064</DOCNO>
	<brief_summary>Study compare percentage treatment success failures patient randomize meloxicam 7.5 mg vs. usual care prescription NSAIDs . Additionally , health care utilization , efficacy safety patient manage healthcare set osteoarthritis ( OA ) hip , knee , hand spine assess .</brief_summary>
	<brief_title>Study Compare Prescription Non-Steroidal Anti-Inflammatory Drug ( NSAID ) Changes , Health Care Utilization , Efficacy Safety Meloxicam 7.5 mg Versus Usual Care Administration Prescription NSAIDs Managed Healthcare Setting Patients With Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Males female age 18 The patient , female reproductive potential ( i.e . neither surgically sterilize postmenopausal ) , must practice adequate contraception ( e.g . intrauterine device , contraceptive pill , DepoProvera , implant double barrier device ) least three month prior duration trial participation must negative pregnancy test screening . Abstinence consider acceptable method contraception . ( It note NSAIDs might interfere effectiveness intrauterine device ) The patient must document diagnosis least one following : Osteoarthritis hip Osteoarthritis knee Osteoarthritis hand Osteoarthritis spine Patients must radiographic confirmation diagnosis The patient willing change require change current prescription NSAID therapy require initiation prescription NSAID therapy treatment OA hip , knee , hand spine The patient intend remain member present Managed Care Organization ( MCO ) duration trial The patient willing comply instruction provide write informed consent The patient know suspected hypersensitivity trial drug excipients , analgesic , antipyretic NSAIDS ( prescription overthecounter ) The patient receive investigational drug use investigational device within 30 day prior enter trial In opinion investigator patient disease condition may result altered absorption , excess accumulation impair metabolism excretion trial medication The patient history recurrent peptic ulcer history ( within past 6 month ) gastrointestinal perforation , peptic ulceration document endoscopy radiography , symptomatic hiatal hernia require daily treatment history gastrointestinal tract hemorrhage , except simple hemorrhoidal bleed The patient currently coumadin might place coumadin course clinical trial Patients dementia , i.e . incapable follow direction comply study protocol Patients coexist rheumatological disorder include rheumatoid arthritis The patient previously participate trial Patients coexist fibromyalgia ankylose spondylitis Patient pregnant lactate Patient severe hepatic failure Patient nondialysed renal failure Patient history GI bleed within past 6 month Patient history cerebrovascular bleed bleed disorder Patient receive concomitant lithium , heparin ticlopidine therapy Patient history leukopenia ( White Blood Cell count &lt; 3500/mmÂ³ ) The patient history platelet count lower limit normal document abnormal prothrombin time ( PT ) partial thromboplastin time ( PTT )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>